While pharmaceutical companies are investing in artificial intelligence, implementation remains the biggest challenge, according to data and analytics firm GlobalData.
The tool is designed to analyze the CDMO’s data to accelerate root cause analysis and corrective action development for deviations and complaints across its manufacturing network.
The new Florida facility enables coordinated supply of critical in vitro transcription materials from research through commercial-scale RNA therapeutic production.
